These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 34558459)
1. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019. Kumari P; Gupta UD; Bhagyawant SS Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459 [TBL] [Abstract][Full Text] [Related]
3. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Charoenlap S; Piromsopa K; Charoenlap C Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943 [TBL] [Abstract][Full Text] [Related]
4. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic. Aspatwar A; Gong W; Wang S; Wu X; Parkkila S Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271 [TBL] [Abstract][Full Text] [Related]
5. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142 [TBL] [Abstract][Full Text] [Related]
6. Are BCG-induced non-specific effects adequate to provide protection against COVID-19? Vashishtha VM Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516 [TBL] [Abstract][Full Text] [Related]
7. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723 [TBL] [Abstract][Full Text] [Related]
8. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115 [TBL] [Abstract][Full Text] [Related]
9. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature. Ręka G; Korzeniowska A; Piecewicz-Szczęsna H Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218 [TBL] [Abstract][Full Text] [Related]
10. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19. Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464 [TBL] [Abstract][Full Text] [Related]
11. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis. Tomita Y; Sato R; Ikeda T; Sakagami T Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070 [TBL] [Abstract][Full Text] [Related]
12. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers. Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672 [TBL] [Abstract][Full Text] [Related]
13. BCG vaccination in health care providers and the protection against COVID-19. Netea MG; van der Meer JW; van Crevel R J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33306484 [TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial. Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606 [TBL] [Abstract][Full Text] [Related]
15. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base. Nachega JB; Maeurer M; Sam-Agudu NA; Chakaya J; Katoto PDM; Zumla A Int J Infect Dis; 2021 Dec; 113 Suppl 1():S78-S81. PubMed ID: 33794380 [TBL] [Abstract][Full Text] [Related]
16. Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19. Zapolnik P; Kmiecik W; Mazur A; Czajka H Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834629 [TBL] [Abstract][Full Text] [Related]
17. The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19. Wang J; Zhang Q; Wang H; Gong W Front Biosci (Landmark Ed); 2022 May; 27(5):157. PubMed ID: 35638424 [TBL] [Abstract][Full Text] [Related]
18. Fiction and Facts about BCG Imparting Trained Immunity against COVID-19. Kaur G; Singh S; Nanda S; Zafar MA; Malik JA; Arshi MU; Lamba T; Agrewala JN Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891168 [TBL] [Abstract][Full Text] [Related]
19. The BCG Vaccine for COVID-19: First Verdict and Future Directions. Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J Front Immunol; 2021; 12():632478. PubMed ID: 33763077 [TBL] [Abstract][Full Text] [Related]
20. BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check. Pandita A; Bhat A; Koul A; Singh SK Curr Pharm Biotechnol; 2021; 22(12):1574-1583. PubMed ID: 33530904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]